Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan · Delayed Price · Currency is TWD 31.80
-0.05 (-0.16%)
At close: Jul 9, 2026
Nang Kuang Pharmaceutical Market Cap
Nang Kuang Pharmaceutical has a market cap or net worth of 3.21 billion as of July 9, 2026. Its market cap has decreased by -12.52% in one year.
Market Cap
3.21B
Enterprise Value
3.58B
Revenue
2.11B
Ranking
n/a
PE Ratio
15.74
Stock Price
31.80
Market Cap Chart
Since May 12, 2006, Nang Kuang Pharmaceutical's market cap has increased from 1.08B to 3.21B, an increase of 196.67%. That is a compound annual growth rate of 5.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.21B | -14.75% |
| Dec 31, 2025 | 3.77B | -9.36% |
| Dec 31, 2024 | 4.16B | -22.80% |
| Dec 29, 2023 | 5.38B | -16.59% |
| Dec 30, 2022 | 6.45B | 65.97% |
| Dec 30, 2021 | 3.89B | -2.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacific Hospital Supply | 5.90B |
| Formosa Optical Technology | 5.36B |
| St.Shine Optical | 4.88B |
| Bionime | 4.41B |
| SciVision Biotech | 4.00B |
| Maxigen Biotech | 3.65B |
| ICARES Medicus | 3.60B |
| Crystalvue Medical | 1.87B |